Metastatic breast cancer Archives - Baylor College of Medicine Blog Network

A new strategy to refine breast cancer diagnosis could help guide a more precise selection of tumor-specific treatments.

From The Labs

Interferon linked to ER+/HER- metastatic breast cancer resistance to therapy

March 12, 2021 CDK4/6 inhibitor therapy, endocrine therapy, ER+/HER2- breast cancer, Interferon, Metastatic breast cancer, Research, resistance to cancr treatment

Both preclinical models and tumor samples from patients with ER+/HER2- breast cancer link high IFN signaling to resistance to treatment.

From The Labs

Becoming metastatic: how FOXA1 triggers metastatic behavior in breast cancer

January 16, 2020 endocrine resistant breast cancer, ER positive breast cancer, FOXA1, HIF-2a, Metastatic breast cancer, Research

About 75 percent of breast cancers have estrogen receptors, hence they are called estrogen receptor positive (ER+). Original ER+ breast cancer cells depend on estrogen

Momentum

Understanding the importance of metastatic breast cancer research

October 17, 2018 Allison Mickey, Breast Cancer, Lester and Sue Smith Breast Center, Metastatic breast cancer, Research

Dr. Suzanne Fuqua shares what inspired her to get involved in metastatic breast cancer research and how she is educating the public about scientific advances at Baylor College of Medicine and beyond.

From The Labs

A new HER2 mutation leads to a clinical trial and to a promising diagnostic tool for metastatic breast cancer

July 27, 2017 circulating tumor DNA, clinical trial, HER2 gene, Metastatic breast cancer, neratinib

There is a group of metastatic breast cancers that has the HER2 gene amplified – the cells have many copies of it – which leads